当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:159.72亿  总市值:160.59亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,584,569,272.241,555,296,988.11726,174,326.793,608,810,283.53
  收到的税费返还598,602.76--428,944.25
  收到其他与经营活动有关的现金170,474,228.69121,738,224.4354,979,606.38303,035,186.4
  经营活动现金流入小计2,755,642,103.691,677,035,212.54781,153,933.173,912,274,414.18
  购买商品、接受劳务支付的现金1,513,901,904.251,027,674,586.25468,260,065.571,946,531,447.59
  支付给职工以及为职工支付的现金775,921,802545,067,176.07288,309,965.331,056,596,892.61
  支付的各项税费90,229,418.0170,039,885.0742,735,734.05135,022,456.77
  支付其他与经营活动有关的现金482,123,964.64311,073,918.18163,201,724.33837,338,459.73
  经营活动现金流出小计2,862,177,088.91,953,855,565.57962,507,489.283,975,489,256.7
  经营活动产生的现金流量净额-106,534,985.21-276,820,353.03-181,353,556.11-63,214,842.52
二、投资活动产生的现金流量:
  收回投资收到的现金4,704,906,591.543,202,083,632.231,715,836,006.296,011,331,867.58
  取得投资收益收到的现金44,715,861.6330,911,201.4116,513,434.4273,316,859.54
  处置固定资产、无形资产和其他长期资产收回的现金净额31,681,783.9529,366,640.9365,380.476,054,606.51
  处置子公司及其他营业单位收到的现金净额6.926.926.92-
  收到的其他与投资活动有关的现金186,184.43186,184.43--
  投资活动现金流入小计4,781,490,428.473,262,547,665.891,732,714,828.16,090,703,333.63
  购建固定资产、无形资产和其他长期资产支付的现金319,728,513.3237,155,791.91173,315,399.68505,923,268.2
  投资支付的现金4,812,373,309.683,113,651,762.81,473,589,292.966,597,967,366.82
  支付其他与投资活动有关的现金186,184.43186,184.43-12,001,775.73
  投资活动现金流出小计5,132,288,007.413,350,993,739.141,646,904,692.647,115,892,410.75
  投资活动产生的现金流量净额-350,797,578.94-88,446,073.2585,810,135.46-1,025,189,077.12
三、筹资活动产生的现金流量:
  取得借款收到的现金225,000,000--570,960,000
  收到其他与筹资活动有关的现金33,825,689.7633,825,689.76-69,200,215
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计258,825,689.7633,825,689.76-640,160,215
  偿还债务支付的现金88,446,00062,398,00028,898,000434,441,873.18
  分配股利、利润或偿付利息支付的现金11,560,585.657,313,192.853,708,331.3517,284,157.55
  支付其他与筹资活动有关的现金283,847,751.2827,128,470.18,167,141.9338,575,658.04
  筹资活动现金流出小计383,854,336.9396,839,662.9540,773,473.28490,301,688.77
  筹资活动产生的现金流量净额-125,028,647.17-63,013,973.19-40,773,473.28149,858,526.23
四、汇率变动对现金及现金等价物的影响-39,482,958.37-29,901,643.04-17,034,709.79-1,550,675.11
五、现金及现金等价物净增加额-621,844,169.69-458,182,042.51-153,351,603.72-940,096,068.52
  加:期初现金及现金等价物余额1,758,430,546.181,758,430,546.181,758,321,155.882,698,417,224.4
  期末现金及现金等价物余额1,136,586,376.491,300,248,503.671,604,969,552.161,758,321,155.88
补充资料:
  净利润-47,779,923.37--637,805,702.62
  资产减值准备-94,456,667.79-485,627,267.37
  固定资产和投资性房地产折旧-178,698,850.6-408,396,255.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-178,698,850.6-408,396,255.92
  无形资产摊销-37,351,994.44-76,038,256.62
  长期待摊费用摊销-15,522,331.79-49,510,967.53
  处置固定资产、无形资产和其他长期资产的损失--1,480,692.69-336,061.07
  固定资产报废损失-1,301,560.52-4,356,878.64
  公允价值变动损失--25,192,564.11-11,291,407.29
  财务费用--13,353,810.81--16,866,315.43
  投资损失-5,674,466.99--12,957,568.69
  递延所得税--3,943,602.9--14,018,941.29
  其中:递延所得税资产减少--7,898,480.43--5,550,624.09
    递延所得税负债增加-3,954,877.53--8,468,317.2
  存货的减少--26,725,973.74-86,419,672.02
  经营性应收项目的减少--324,862,234.34--244,438,338.19
  经营性应付项目的增加--276,984,281.39--234,769,844.39
  其他----57,852,628.01
  不涉及现金收支的投资和筹资活动金额其他项目-4,969,180.66-65,287,712.95
  现金的期末余额-1,300,248,503.67-1,758,321,155.88
  减:现金的期初余额-1,758,430,546.18-2,698,417,224.4
  现金及现金等价物的净增加额--458,182,042.51--940,096,068.52
公告日期2026-10-242026-08-222026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑